B Viron

2.4k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

B Viron is a scholar working on Nephrology, Surgery and Hematology. According to data from OpenAlex, B Viron has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 8 papers in Surgery and 8 papers in Hematology. Recurrent topics in B Viron's work include Dialysis and Renal Disease Management (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). B Viron is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). B Viron collaborates with scholars based in France, Belgium and Switzerland. B Viron's co-authors include Nicole Casadevall, Jean‐Jacques Kiladjian, Patrick Mayeux, Bruno Varet, T. Papo, Irène Teyssandier, Patrick A. Michaud, P Martin-Dupont, J Nataf and Valérie Ugo and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Kidney International.

In The Last Decade

B Viron

39 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

2002 843 citations Nicole Casadevall, J Nataf et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Viron France	12	474	400	317	300	244	40	1.4k
C. Chapman United Kingdom	28	246 0.5×	852 2.1×	281 0.9×	90 0.3×	168 0.7×	77	2.4k
Roberto Dall’Amico Italy	22	539 1.1×	658 1.6×	156 0.5×	192 0.6×	124 0.5×	62	2.0k
Joung-Liang Lan Taiwan	17	1.3k 2.7×	196 0.5×	285 0.9×	309 1.0×	718 2.9×	24	3.2k
Nicholas Bandarenko United States	19	697 1.5×	616 1.5×	106 0.3×	299 1.0×	52 0.2×	36	1.9k
D. R. Norfolk United Kingdom	21	301 0.6×	728 1.8×	134 0.4×	115 0.4×	47 0.2×	65	1.7k
Valderílio Feijó Azevedo Brazil	22	921 1.9×	381 1.0×	194 0.6×	159 0.5×	68 0.3×	116	1.8k
Eleanor L. Ramos United States	21	354 0.7×	109 0.3×	134 0.4×	293 1.0×	218 0.9×	43	2.5k
M Vest Switzerland	8	486 1.0×	748 1.9×	133 0.4×	75 0.3×	161 0.7×	22	1.5k
Birgit Gathof Germany	23	191 0.4×	380 0.9×	377 1.2×	41 0.1×	65 0.3×	82	1.6k
Luc De Pauw Belgium	19	302 0.6×	77 0.2×	90 0.3×	119 0.4×	99 0.4×	44	1.2k

Countries citing papers authored by B Viron

Since Specialization

Citations

This map shows the geographic impact of B Viron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Viron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Viron more than expected).

Fields of papers citing papers by B Viron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Viron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Viron. The network helps show where B Viron may publish in the future.

Co-authorship network of co-authors of B Viron

This figure shows the co-authorship network connecting the top 25 collaborators of B Viron. A scholar is included among the top collaborators of B Viron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Viron. B Viron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bollée, Guillaume, Benoît Guéry, Dominique Joly, et al.. (2008). Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing Dialysis. Clinical Journal of the American Society of Nephrology. 3(2). 375–381. 41 indexed citations

Viron, B, et al.. (2008). Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs. Nephrology Dialysis Transplantation. 23(7). 2416–2418. 4 indexed citations

Dürrbach, Antoine, Lionel Rostaing, Nacéra Ouali, et al.. (2004). USE OF SIROLIMUS AS INITIAL THERAPY AFTER RENAL TRANSPLANTATION : PRELIMINARY RESULTS OF A RANDOMIZED PILOT STUDY IN PATIENT RECEIVING MARGINAL KIDNEYS. Transplantation. 78. 228–228. 3 indexed citations

Dahan, Karin, Olivier Devuyst, Didier Vertommen, et al.. (2003). A Cluster of Mutations in the UMOD Gene Causes Familial Juvenile Hyperuricemic Nephropathy with Abnormal Expression of Uromodulin. Journal of the American Society of Nephrology. 14(11). 2883–2893. 161 indexed citations

Casadevall, Nicole, J Nataf, B Viron, et al.. (2002). Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin. New England Journal of Medicine. 346(7). 469–475. 843 indexed citations breakdown →

Viron, B, et al.. (2002). [Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance].. PubMed. 23(1). 19–22. 2 indexed citations

Viron, B. (2002). [The point about...uremia and cancer].. PubMed. 23(6). 231–6. 1 indexed citations

Hiesse, C, Marc Busson, Claude Buisson, et al.. (2001). Multicenter trial of one HLA-DR–matched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney International. 60(1). 341–349. 18 indexed citations

Laissy, Jean‐Pierre, et al.. (1999). Failing Arteriovenous Hemodialysis Fistulas. Investigative Radiology. 34(3). 218–224. 18 indexed citations

10.

Dahan, Michel, P. Siohan, B Viron, et al.. (1997). Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study. American Journal of Kidney Diseases. 30(6). 780–785. 29 indexed citations

11.

Mignon, F, et al.. (1995). The management of uraemia in the elderly: treatment choices. Nephrology Dialysis Transplantation. 10(supp6). 55–59. 24 indexed citations

12.

Viron, B, et al.. (1994). Autoimmune haemolytic anaemia after ABO-match, ABDR full match kidney transplantation. Nephrology Dialysis Transplantation. 9(6). 693–697. 11 indexed citations

13.

Mignon, F, et al.. (1993). Worldwide demographics and future trends of the management of renal failure in the elderly.. PubMed. 41. S18–26. 33 indexed citations

14.

Morinière, P, B Viron, B Bourgeon, et al.. (1993). Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.. PubMed. 41. S121–4. 7 indexed citations

15.

Michel, Catherine, P Dosquet, Pierre Ronco, et al.. (1992). Nephropathy Associated with Infection by Human Immunodeficiency Virus: A Report on 11 Cases Including 6 Treated with Zidovudine. The Nephron journals/Nephron journals. 62(4). 434–440. 49 indexed citations

16.

Singlas, E, A M Taburet, A Sobel, et al.. (1992). Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis. Antimicrobial Agents and Chemotherapy. 36(7). 1519–1524. 25 indexed citations

17.

Mignon, F, et al.. (1992). End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge.. PubMed. 1(5). 302–7. 6 indexed citations

18.

Viron, B, et al.. (1991). Delayed Extensive Arterial Dissection after Percutaneous Transluminal Angioplasty for Transplant Renal Artery Stenosis. The Nephron journals/Nephron journals. 58(3). 351–353. 3 indexed citations

19.

Viron, B, Martine De Meyer, A. Le Liboux, et al.. (1990). Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.. PubMed. 5 Suppl 2. 95–104. 6 indexed citations

20.

Viron, B, et al.. (1989). Experience with the Hemasite Vascular Prosthesis. Artificial Organs. 13(2). 159–162. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact